Research output per year
Research output per year
Personal profile
Research interests
Mika Kontro, MD, PhD is an adjunct professor and a consultant in clinical hematology at the Helsinki University Hospital Comprehensive Cancer Center. Mika Kontro earned his PhD thesis, entitled “Individualizing therapy for acute leukemia”, in 2017.
He currently works as K. Albin Johannson Cancer Research Fellow (Finnish Cancer Institute) and as a group leader in FIMM. He has a strong background in running clinical trials and was selected at 2017 for European Hematology Association Clinical Research Training program (CRTH). Mika Kontro currently chairs the Finnish AML group and is a board member of the Nordic AML Group. Currently he leads a prospective multi-center AML trial VenEx utilizing ex-vivo drug sensitivity testing for individualized patient care.
Fields of Science
- 3122 Cancers
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Bexmarilimab plus azacitidine for high-risk myelodysplastic syndrome and relapsed or refractory acute myeloid leukaemia: results from the dose-escalation part of a multicentre, single-arm, phase 1/2 trial
Kontro, M., Stein, A. S., Pyörälä, M., Rimpiläinen, J., Siitonen, T., Ylitalo, A., Fjällskog, M.-L., Jalkanen, J., Aakko, S., Pawlitzky, I., Hollmén, M. & Daver, N., 2025, In: The Lancet Haematology.Research output: Contribution to journal › Article › Scientific › peer-review
-
Capillary Sampling Enables Venetoclax Concentration Measurement in Acute Myeloid Leukaemia Within Academic Multicentre Trial
Kytölä, S., Kurkela, M., Kiiski, J., Vänttinen, I., Ruokoranta, T., Partanen, A., Holopainen, A., Pyörälä, M., Kuusisto, M. L., Siitonen, T., Koskela, S., Rimpiläinen, J., Ettala, P., Kuusanmäki, H., Niemi, M., Backman, J. & Kontro, M., Jun 2025, In: Basic and Clinical Pharmacology and Toxicology. 136, 6, 11 p., e70041.Research output: Contribution to journal › Article › Scientific › peer-review
-
CLEVER-1 targeting antibody, bexmarilimab, supports HLA-DR expression and alters ex vivo responsiveness to azacitidine and venetoclax in myeloid malignancies
Aakko, S., Ylitalo, A., Kuusanmäki, H., Rannikko, J. H., Björkman, M., Mandelin, J., Heckman, C. A., Kontro, M. & Hollmen, M., 14 May 2025, In: Scientific Reports. 15, 1, 13 p., 16775.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Ex vivo venetoclax sensitivity predicts clinical response in acute myeloid leukemia in the prospective VenEx trial
Kytölä, S., Vänttinen, I. M., Ruokoranta, T., Partanen, A., Holopainen, A., Saad, J., Kuusisto, M. E. L., Koskela, S., Räty, R., Itälä-Remes, M., Västrik, I., Suvela, M., Parsons, A. O., Porkka, K., Wennerberg, K., Heckman, C. A., Jalkanen, T., Huttunen, T., Ettala, P. & Rimpiläinen, J. & 4 others, , 23 Jan 2025, In: Blood. 145, 4, p. 409-421 13 p.Research output: Contribution to journal › Article › Scientific › peer-review
-
Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century
Hemminki, K., Zitricky, F., Försti, A., Kontro, M., Gjertsen, B. T., Severinsen, M. T. & Juliusson, G., 14 Mar 2024, In: Blood cancer journal. 14, 1, 4 p., 44.Research output: Contribution to journal › Comment/debate › Scientific › peer-review
Open AccessFile
-
Kontro Jusélius 1/3 2025-28
Kontro, M. (Project manager)
Sigrid Juséliuksen Säätiö @003701165704@
01/05/2025 → 30/04/2026
Project: Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)
-
Kontro Syöpäsäätiö 2024-25
Kontro, M. (Project manager) & Kuusanmäki, H. (Participant)
Syöpäsäätiö sr Cancerstiftelsen sr
01/01/2024 → 31/12/2025
Project: Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)
-
Kontro/Suomen Hematologiyhdist.apuraha
Kontro, M. (Project manager)
Suomen hematologiyhdistys ry (SHY)
15/02/2023 → 31/12/2026
Project: Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)
-
AMLDT: A Prototype System for AML Digital Twins
Kontro, M. (Project manager) & Vänttinen, I. M. (Participant)
Suomen Akatemia Projektilaskutus
01/01/2023 → 31/12/2027
Project: Research Council of Finland: Bilateral partnerships, joint calls
-
VenEx prospective clinical trial
Västrik, I. (Participant) & Kontro, M. (Project manager)
02/03/2020 → …
Project: Research project
-
Eurooppalainen tutkijoiden yö
Liljeström, M. (Member of organizing committee), Kaunisto, M. (Member of organizing committee), Kauppi, L. (Speaker: Presenter), Vähärautio, A. (Speaker: Presenter), Kontro, M. (Speaker: Presenter) & Ahlnäs, K. (Member of organizing committee)
27 Sept 2024Activity: Participating in or organising an event types › Organisation and participation in conferences, workshops, courses, seminars
-
Patient-researcher meetup, hematological cancers
Liljeström, M. (Participant), Mustjoki, S. (Participant), Kontro, M. (Participant), Heckman, C. (Participant), Porkka, K. (Participant), Klievink, J. (Participant), Decombis, S. (Participant), Miettinen, J. (Participant), De Lorenzo, F. (Participant) & Suvela, M. (Participant)
9 Sept 2024Activity: Other activity types › Other